Medicinova (MNOV) Change in Accured Expenses (2010 - 2025)

Medicinova (MNOV) has 16 years of Change in Accured Expenses data on file, last reported at $582390.0 in Q4 2025.

• On a quarterly basis, Change in Accured Expenses rose 64.87% year-over-year to $582390.0 in Q4 2025; TTM through Dec 2025 was $459871.0, a 247.23% increase from a year earlier, with the FY2025 full-year figure at $459871.0, up 247.23% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at $582390.0, up from $163331.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for MNOV reached as high as $844759.0 in Q2 2022 and fell as low as -$1.4 million in Q4 2021.
• Historically, Change in Accured Expenses has averaged -$26537.6 across 5 years, with a median of $79076.5 in 2021.
• Across the five-year window, Change in Accured Expenses plunged 512.43% in 2023 and soared 103870.22% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$1.4 million in 2021, then gained by 1.9% to -$1.3 million in 2022, then jumped by 135.82% to $476913.0 in 2023, then slipped by 25.93% to $353245.0 in 2024, then jumped by 64.87% to $582390.0 in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $582390.0 in Q4 2025, $163331.0 in Q3 2025, and $527129.0 in Q2 2025.